{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:04:26Z","timestamp":1793131466964,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00246-023-03332-5","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T14:01:44Z","timestamp":1698933704000},"page":"81-88","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Experience with SGLT2 Inhibitors in Patients with Single Ventricle Congenital Heart Disease and Fontan Circulatory Failure"],"prefix":"10.1007","volume":"46","author":[{"given":"Anusha","family":"Konduri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Lowery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Jarosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunkyung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heang M.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda D.","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt R.","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"issue":"6","key":"3332_CR1","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1161\/CIR.0000000000000696","volume":"140","author":"J Rychik","year":"2019","unstructured":"Rychik J et al (2019) Evaluation and management of the child and adult with fontan circulation: a scientific statement from the American heart association. Circulation 140(6):e234\u2013e284. https:\/\/doi.org\/10.1161\/CIR.0000000000000696","journal-title":"Circulation"},{"issue":"18","key":"3332_CR2","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1136\/heartjnl-2019-315862","volume":"106","author":"C Poh","year":"2020","unstructured":"Poh C et al (2020) Modes of late mortality in patients with a fontan circulation. Heart 106(18):1427\u20131431. https:\/\/doi.org\/10.1136\/heartjnl-2019-315862","journal-title":"Heart"},{"issue":"18","key":"3332_CR3","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA et al (2022) 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines. Circulation 145(18):e895\u2013e1032. https:\/\/doi.org\/10.1161\/CIR.0000000000001063","journal-title":"Circulation"},{"issue":"6","key":"3332_CR4","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","volume":"5","author":"GD Lopaschuk","year":"2020","unstructured":"Lopaschuk GD, Verma S (2020) Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review. JACC Basic Transl Sci 5(6):632\u2013644. https:\/\/doi.org\/10.1016\/j.jacbts.2020.02.004","journal-title":"JACC Basic Transl Sci"},{"issue":"4","key":"3332_CR5","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/chd.12368","volume":"11","author":"WM Book","year":"2016","unstructured":"Book WM, Gerardin J, Saraf A, Valente AM, Rodriguez F III (2016) Clinical phenotypes of fontan failure: implications for management. Congenit Heart Dis 11(4):296\u2013308. https:\/\/doi.org\/10.1111\/chd.12368","journal-title":"Congenit Heart Dis"},{"key":"3332_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2021.01.022","author":"B Bozkurt","year":"2021","unstructured":"Bozkurt B et al (2021) Universal definition and classification of heart failure: a report of the heart failure society of America, heart failure association of the European society of cardiology, Japanese heart failure society and writing committee of the universal definition of heart failure. J Card Fail. https:\/\/doi.org\/10.1016\/j.cardfail.2021.01.022","journal-title":"J Card Fail"},{"issue":"2","key":"3332_CR7","doi-asserted-by":"publisher","first-page":"e010123","DOI":"10.1161\/CIRCHEARTFAILURE.122.010123","volume":"16","author":"AM Lubert","year":"2023","unstructured":"Lubert AM et al (2023) Considerations for advanced heart failure consultation in individuals with fontan circulation: recommendations from ACTION. Circ Heart Fail 16(2):e010123. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.122.010123","journal-title":"Circ Heart Fail"},{"key":"3332_CR8","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3389\/fpsyg.2013.00863","volume":"4","author":"D Lakens","year":"2013","unstructured":"Lakens D (2013) Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Front Psychol 4:863. https:\/\/doi.org\/10.3389\/fpsyg.2013.00863","journal-title":"Front Psychol"},{"issue":"10","key":"3332_CR9","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","volume":"128","author":"GD Lopaschuk","year":"2021","unstructured":"Lopaschuk GD, Karwi QG, Tian R, Wende AR, Abel ED (2021) Cardiac energy metabolism in heart failure. Circulation Res 128(10):1487\u20131513. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318241","journal-title":"Circulation Res"},{"issue":"21","key":"3332_CR10","doi-asserted-by":"publisher","first-page":"e012086","DOI":"10.1161\/JAHA.119.012086","volume":"8","author":"AC Koop","year":"2019","unstructured":"Koop AC, Bossers GPL, Ploegstra MJ, Hagdorn QAJ, Berger RMF, Sillje HHW, Bartelds B (2019) Metabolic remodeling in the pressure-loaded right ventricle: shifts in glucose and fatty acid metabolism-a systematic review and meta-analysis. J Am Heart Assoc 8(21):e012086. https:\/\/doi.org\/10.1161\/JAHA.119.012086","journal-title":"J Am Heart Assoc"},{"key":"3332_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijcard.2017.11.118","volume":"257","author":"D Lee","year":"2018","unstructured":"Lee D et al (2018) Chronic kidney damage in the adult fontan population. Int J Cardiol 257:62\u201366. https:\/\/doi.org\/10.1016\/j.ijcard.2017.11.118","journal-title":"Int J Cardiol"},{"key":"3332_CR12","doi-asserted-by":"publisher","first-page":"104215","DOI":"10.1016\/j.ebiom.2022.104215","volume":"83","author":"YM Gao","year":"2022","unstructured":"Gao YM, Feng ST, Wen Y, Tang TT, Wang B, Liu BC (2022) Cardiorenal protection of SGLT2 inhibitors-perspectives from metabolic reprogramming. EBioMedicine 83:104215. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104215","journal-title":"EBioMedicine"},{"issue":"2","key":"3332_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10741-020-10024-2","volume":"26","author":"D Margonato","year":"2021","unstructured":"Margonato D, Galati G, Mazzetti S, Cannistraci R, Perseghin G, Margonato A, Mortara A (2021) Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors. Heart Fail Rev 26(2):337\u2013345. https:\/\/doi.org\/10.1007\/s10741-020-10024-2","journal-title":"Heart Fail Rev"},{"key":"3332_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2023.03.011","author":"J Saef","year":"2023","unstructured":"Saef J, Sundaravel S, Ortega-Legaspi J, Vaikunth S (2023) Safety and treatment experience with sodium\/glucose cotransporter-2 inhibitors in adult patients with congenital heart disease. J card Fail. https:\/\/doi.org\/10.1016\/j.cardfail.2023.03.011","journal-title":"J card Fail"},{"issue":"7","key":"3332_CR15","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.cjca.2022.04.014","volume":"38","author":"N Perrin","year":"2022","unstructured":"Perrin N et al (2022) The fontan circulation: from ideal to failing hemodynamics and drug therapies for optimization. Can J Cardiol 38(7):1059\u20131071. https:\/\/doi.org\/10.1016\/j.cjca.2022.04.014","journal-title":"Can J Cardiol"},{"key":"3332_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ijcard.2022.03.018","volume":"357","author":"M Brida","year":"2022","unstructured":"Brida M, Lovric D, Griselli M, Riesgo Gil F, Gatzoulis MA (2022) Heart failure in adults with congenital heart disease. Int J Cardiol 357:39\u201345. https:\/\/doi.org\/10.1016\/j.ijcard.2022.03.018","journal-title":"Int J Cardiol"},{"key":"3332_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-022-02983-0","author":"DM Newland","year":"2022","unstructured":"Newland DM, Law YM, Albers EL, Friedland-Little JM, Ahmed H, Kemna MS, Hong BJ (2022) Early clinical experience with dapagliflozin in children with heart failure. Pediatric Cardiol. https:\/\/doi.org\/10.1007\/s00246-022-02983-0","journal-title":"Pediatric Cardiol"},{"key":"3332_CR18","doi-asserted-by":"publisher","first-page":"5243594","DOI":"10.1155\/2022\/5243594","volume":"2022","author":"J Muneuchi","year":"2022","unstructured":"Muneuchi J, Sugitani Y, Kobayashi M, Ezaki H, Yamada H, Watanabe M (2022) Feasibility and safety of sodium glucose cotransporter-2 inhibitors in adults with heart failure after the fontan procedure. Case Rep Cardiol 2022:5243594. https:\/\/doi.org\/10.1155\/2022\/5243594","journal-title":"Case Rep Cardiol"},{"key":"3332_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2884","author":"DA Pascual-Figal","year":"2023","unstructured":"Pascual-Figal DA et al (2023) Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: the DAPA-MODA study. Eur J Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.2884","journal-title":"Eur J Heart Fail"},{"issue":"19","key":"3332_CR20","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/j.jacc.2007.02.037","volume":"49","author":"GC Fonarow","year":"2007","unstructured":"Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M (2007) Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 49(19):1943\u20131950. https:\/\/doi.org\/10.1016\/j.jacc.2007.02.037","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"3332_CR21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cardfail.2011.04.012","volume":"17","author":"MR Shah","year":"2011","unstructured":"Shah MR et al (2011) The STARBRITE trial: a randomized, pilot study of B-type natriuretic peptide-guided therapy in patients with advanced heart failure. J Card Fail 17(8):613\u2013621. https:\/\/doi.org\/10.1016\/j.cardfail.2011.04.012","journal-title":"J Card Fail"},{"issue":"18","key":"3332_CR22","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.jacc.2011.03.072","volume":"58","author":"JL Januzzi Jr.","year":"2011","unstructured":"Januzzi JL Jr. et al (2011) Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction. J Am Coll Cardiol 58(18):1881\u20131889. https:\/\/doi.org\/10.1016\/j.jacc.2011.03.072","journal-title":"J Am Coll Cardiol"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-023-03332-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-023-03332-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-023-03332-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T11:33:15Z","timestamp":1737372795000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00246-023-03332-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3332"],"URL":"https:\/\/doi.org\/10.1007\/s00246-023-03332-5","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"assertion":[{"value":"1 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors do not have any conflict of interests, financial or otherwise, to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}